AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 53
- Registration Number
- NCT00918515
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT00918398
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg
Phase 3
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Placebo matching Metformin XR
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 219
- Registration Number
- NCT00918138
- Locations
- 🇺🇸
Dedicated Phase I, Inc., Phoenix, Arizona, United States
🇺🇸Palm Springs Research Institute, Hialeah, Florida, United States
🇺🇸River Birch Research Alliance, Llc, Blue Ridge, Georgia, United States
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 691
- Registration Number
- NCT00917267
- Locations
- 🇨🇳
Research Site, Taoyuan, Taiwan
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2009-11-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00916604
- Locations
- 🇯🇵
Research Site, Tokyo, Japan
Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey
Completed
- Conditions
- Diabetes
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 5926
- Registration Number
- NCT00916513
- Locations
- 🇬🇧
Research Site, St Albans, United Kingdom
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 228
- Registration Number
- NCT00915356
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
Completed
- Conditions
- Gastroesophageal Reflux Disease
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 889
- Registration Number
- NCT00914342
- Locations
- 🇬🇷
Research Site, Xanthi, Greece
Quality Project to Evaluate and Validate the FAST-O Rating Scale
Completed
- Conditions
- Acute Psychotic Symptoms
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2009-10-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 111
- Registration Number
- NCT00913731
- Locations
- 🇸🇪
Research Site, Ystad, Sweden
Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2010-04-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 77
- Registration Number
- NCT00914303
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden